Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Measles Immunity Status in Iranian Infants and Children and Outbreak Concerns: Time for Reconsidering the Vaccination Schedule? Publisher Pubmed



Pourakbari B1 ; Ashraf Talesh S2 ; Mahmoudi S3 ; Sotoudeh M4 ; Hosseinpour Sadeghi R1 ; Mamishi S1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Biotechnology Centre, Silesian University of Technology, Gliwice, 44-100, Poland
  4. 4. Molecular Pathology and Cytogenetics Division, Pathology Department, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Vaccine Published:2024


Abstract

Introduction: Measles vaccination has greatly reduced the disease burden worldwide, but challenges remain due to variations in vaccine effectiveness across age groups. This study aimed to assess the serological profile of measles antibodies across different age groups, evaluate the impact of maternal immunity on antibody levels in infants under 12 months, and assess measles immunity in vaccinated individuals. Material and methods: This cross-sectional study was conducted from June 2022 to January 2023 at the Children's Medical Center, a referral hospital in Iran. Serum samples were tested for measles-specific IgG and IgM antibodies using a commercial enzyme-linked immunosorbent assay (ELSA). An avidity assay was performed to assess measles virus-specific IgG antibodies on the samples that were positive and borderline for the measles IgG ELISA. Results: The study included 969 participants across various age groups. Among them, 23% (221 out of 953) tested positive for measles IgM ELISA, and 52% (504 out of 969) for measles IgG ELISA. Regarding the avidity assay for measles virus-specific IgG, the majority (418 out of 573, 73%) showed high-avidity antibodies. Measles-specific IgG levels varied significantly across different age groups, with infants below 6 months old showing a mean IgG level of 477 mIU/mL, declining to 230 mIU/mL between 6 and 12 months, and increasing significantly to 683 mIU/mL in the 12 to 18 month age group, reaching a peak at 938 mIU/mL among children aged 18–72 months. Conclusion: The increasing IgM positivity among young Iranians suggests a rising risk of measles outbreaks, possibly due to vaccination gaps. Inadequate antibody levels in infants raise concerns about vaccination effectiveness. Considering declining maternal antibodies, vaccinating infants at 6–9 months could be beneficial. Boosters for adolescents and women may further mitigate outbreak risks. © 2024
Related Docs
View other Related Docs
1. Measles and Rubella Serosusceptibity Among Population Vaccinated With Different Schedules: The Potential Impact on Measles-Rubella Elimination in Iran, BMC Infectious Diseases (2021)
2. Seroconversion Rates Following 2 Doses of Measles- Mumps- Rubella Vaccination Given at the Ages 12 and 18 Months: Data for Possible Additional Dose at Older Age, BMC Immunology (2022)
3. Investigation of the Seroprevalence of Antimeasles Immunoglobulin G Antibody in Students at Shiraz University of Medical Sciences, Viral Immunology (2023)
4. Seroprevalence of Anti-Rubella and Anti-Measles Antibodies in Women at the Verge of Marriage in Iran, Vaccine (2020)
5. Serological Status of Measles, Mumps, and Rubella Antibodies in Hiv-Positive Women of Childbearing Age at a Referral Hospital in Iran, AIDS Research and Therapy (2025)
6. A Nationwide Study on the Seroprevalence of Measles, Mumps, and Rubella in Iranian Children and Adolescents, Iranian Journal of Public Health (2022)
7. Seroprevalence of Antibodies to Measles and Rubella Eight Months After a Vaccination Campaign in the Southeast of Iran, Human Vaccines and Immunotherapeutics (2018)
8. Genetic Characterization of Measles Virus Circulating in Iran, 2021–2023, BMC Infectious Diseases (2025)
Experts (# of related papers)
View all Related Experts
Vahid Salimi (3)
Alireza Abdollahi (2)
Other Related Docs
9. Assessing Seropositivity of Mmr Antibodies in Individuals Aged 2–22: Evaluating Routine Vaccination Effectiveness After the 2003 Mass Campaign-A Study From Iran’S National Measles Laboratory, BMC Infectious Diseases (2024)
10. Measles Vaccination Coverage and Seroprevalence of Anti-Measles Antibody in South-East Islamic Republic of Iran; [Couverture Vaccinale Antirougeoleuse Et Seroprevalence Des Anticorps Antirougeoleux Dans Le Sud-Est De La Republique Islamique D'iran], Eastern Mediterranean Health Journal (2015)
11. Head-To-Head Immunogenicity Comparison of Edmonston-Zagreb Vs. Aik-C Measles Vaccine Strains in Infants Aged 8–12 Months: A Randomized Clinical Trial, Vaccine (2018)